Target type: biologicalprocess
Any process that stops, prevents or reduces the frequency, rate or extent of intralumenal vesicle formation. [GO_REF:0000058, GOC:bc, GOC:PARL, GOC:TermGenie, PMID:26911690]
Negative regulation of intralumenal vesicle formation is a critical process in the control of cellular trafficking and communication. Intralumenal vesicles (ILVs) are small, membrane-bound vesicles that bud from the limiting membrane of multivesicular bodies (MVBs). These MVBs are late endosomes that play a crucial role in the sorting and trafficking of proteins and lipids within the cell. ILVs can carry cargo, such as ubiquitinated proteins, to lysosomes for degradation or deliver them to other cellular compartments. The formation of ILVs is tightly regulated to ensure proper sorting and trafficking of cellular components.
The process of negative regulation of ILV formation involves a complex interplay of proteins, lipids, and signaling pathways. Several key mechanisms contribute to this regulation:
1. **Inhibition of ESCRT complex activity:** The ESCRT (Endosomal Sorting Complexes Required for Transport) machinery is essential for ILV formation. It consists of four complexes (ESCRT-0, ESCRT-I, ESCRT-II, and ESCRT-III) that work together to recognize and package cargo into ILVs. Inhibition of ESCRT complex activity can be achieved through several mechanisms:
* **Depletion of ESCRT components:** Reducing the expression or activity of specific ESCRT components, such as Tsg101 or CHMP4B, can disrupt the ESCRT machinery and inhibit ILV formation.
* **Competitive binding of ESCRT interacting proteins:** Proteins that interact with ESCRT components can compete with cargo proteins, hindering their sorting into ILVs.
* **Modification of ESCRT protein activity:** Post-translational modifications, such as phosphorylation or ubiquitination, can alter the activity of ESCRT proteins and affect their ability to function properly.
2. **Regulation of lipid composition:** The lipid composition of the endosomal membrane is critical for ILV formation. Specific lipids, such as phosphatidylinositol 3-phosphate (PI3P), play a role in recruiting ESCRT components and promoting ILV formation. Changes in lipid composition, either through enzymatic modifications or by altering lipid synthesis or degradation, can impact the process.
3. **Signaling pathways:** Signaling pathways, such as the PI3K/Akt pathway, can influence ILV formation by regulating the activity of ESCRT components or by modifying lipid composition.
4. **Regulation by ubiquitination:** Ubiquitination is a post-translational modification that plays a critical role in sorting proteins into ILVs. Proteins destined for degradation are often ubiquitinated and targeted for inclusion in ILVs. Inhibiting ubiquitination or interfering with ubiquitin-binding proteins can disrupt the process.
5. **Other regulatory proteins:** Numerous other proteins are involved in the regulation of ILV formation. These proteins may act as chaperones, scaffold proteins, or regulators of enzymatic activity. They contribute to the fine-tuning of the process and ensure proper control of ILV formation.
Negative regulation of ILV formation is essential for maintaining cellular homeostasis and preventing aberrant trafficking of cellular components. It is crucial for cellular processes such as protein degradation, immune response, and cell signaling. Dysfunction in this process can lead to various pathological conditions, including cancer and neurodegenerative diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Ras-related protein Rab-7a | A Ras-related protein Rab-7a that is encoded in the genome of human. [PRO:DNx, UniProtKB:P51149] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
2-[[benzamido(sulfanylidene)methyl]amino]-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic acid | CID1067700: a pan-GTPase inhibitor; structure in first source | thienopyran | |
guanosine diphosphate | Guanosine Diphosphate: A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. | guanosine 5'-phosphate; purine ribonucleoside 5'-diphosphate | Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor |
guanosine triphosphate | Guanosine Triphosphate: Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. | guanosine 5'-phosphate; purine ribonucleoside 5'-triphosphate | Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor |